References
- De Santo LS, Amarelli C, Romano G, Della Corte A, Maiello C, Giannolo B, et al. 2006. High-risk heart grafts: effective preservation with Celsior solution. Heart Vessels. 21:89–94.
- Doenst T, Bugger H, Schwarzer M, Faerber G, Borger MA, Mohr FW. 2008. Three good reasons for heart surgeons to understand cardiac metabolism. Eur J Cardiothorac Surg. 33:862–871.
- Ferrera R, Larese A, Berthod F, Guidollet J, Rodriguez C, Dureau G, et al. 1993. Quantitative reduction of MTT by hearts biopsies in vitro is an index of viability. J Mol Cell Cardiol. 25:1091.
- Garlicki M. 2003. May preservation solution affect the incidence of graft vasculopathy in transplanted heart? Ann Transplant. 8:19–24.
- Karam G, Compagnon P, Hourmant M, Despins P, Duveau D, Noury D, et al. 2005. A single solution for multiple organ procurement and preservation. Transpl Int. 18:657–663.
- Koike N, Takeyoshi I, Ohki S, Tokumine M, Matsumoto K, Morishita Y. 2004. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors. Transplantation. 77:286–292.
- Kosieradzki M, Rowinski W. 2008. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc. 40:3279–3288.
- Lee S, Huang CS, Kawamura T, Shigemura N, Billiar TR, Nakao A, et al. 2011. Histidine-tryptophan-ketoglutarate or celsior: which is more suitable for cold preservation for cardiac grafts from older donors? Ann Thorac Surg. 91:755–763.
- Lee S, Huang CS, Kawamura T, Shigemura N, Stolz DB, Billiar TR, et al. 2010. Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia. Surgery. 148:463–473.
- Maruyama Y, Chambers DJ. 2012. Ischaemic postconditioning: does cardioplegia influence protection? Eur J Cardiothorac Surg. 42:530–539.
- McCord JM. 1985. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 312:159–163.
- Menasché P, Termignon JL, Pradier F, Grousset C, Mouas C, Alberici G, et al. 1994. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg. 8:207–213.
- Michel P, Vial R, Rodriguez C, Ferrera R. 2002. A comparative study of the most widely used solutions for cardiac graft preservation during hypothermia. J Heart Lung Transplant. 21:1030–1039.
- Perrault LP, El-Hamamsy I, Dumont E, Malo O, Carrier M. 2005. Effects of crystalloid, blood and Celsior solutions on porcine coronary endothelial function after heart transplantation. J Heart Lung Transplant. 24:912–920.
- Rousselot M, Delpy E, Drieu La Rochelle C, Lagente V, Pirow R. 2006. Arenicola marina extracellular hemoglobin: a new promising blood substitute. Biotechnol J. 1:333–345.
- Rudd DM, Dobson GP. 2009. Toward a new cold and warm nondepolarizing, normokalemic arrest paradigm for orthotopic heart transplantation. J Thorac Cardiovasc Surg. 137:198–207.
- Simmons MN, Schreiber MJ, Gill IS. 2008. Surgical renal ischemia: a contemporary overview. J Urol. 180:19–30.
- Snabaitis AK, Chambers DJ. 1999a. Long-term myocardial preservation: beneficial and additive effects of polarized arrest (Na+-channel blockade), Na+/H+-exchange inhibition, and Na+/K+/2Cl- -cotransport inhibition combined with calcium desensitization. Transplantation. 68:1444–1453.
- Snabaitis AK, Shattock MJ, Chambers DJ. 1999b. Long-term myocardial preservation: effects of hyperkalemia, sodium channel, and Na/K/2Cl cotransport inhibition on extracellular potassium accumulation during hypothermic storage. J Thorac Cardiovasc Surg. 118:123–134.
- Snabaitis AK, Shattock MJ, Chambers DJ. 1997. Comparison of polarized and depolarized arrest in the isolated rat heart for long-term preservation. Circulation. 96:3148–3156.
- Thuillier R, Dutheil D, Trieu MT, Mallet V, Allain G, Rousselot M, et al. 2011. Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation. Am J Transplant. 11:1845–1860.